butyricicoccus pullicaecorum
Cell therapyexperimental
Butyricicoccus pullicaecorum is an anaerobic and butyrate-producing bacterium from the genus Butyricicoccus which has been isolated from the cecal content of a broiler chicken in Maldegem in Belgium. — Wikipedia
Clinical trial activity
2 trials · 2 clinical orgs · 0 marketing orgs
Phase 1
1
Phase 2
0
Phase 3
0
Phase 4
0
Earliest trial started Feb 1, 2014 (NCT02477033)
Timeline
2010s
- Jan 1, 2014
Earliest Phase 1 Sponsor(trial)
Indications
Studied for
Mechanism of action
- Unspecified targetUnclear
unclear
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Sources
- WikipediaButyricicoccus pullicaecorum ↗
Also known as
- butyricicoccus pullicaecorum
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT04428606 | N/A | Jun 1, 2020 | University of California, Los Angeles |
| NCT02477033 | Phase 1 | Feb 1, 2014 | Katholieke Universiteit Leuven |
Showing 2 of 2 trials
Page 1 / 1
Organizations
Research & Development (2)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Katholieke Universiteit Leuven | Academic/Hospital | 1 | 1 | 1 | 2014 |
| University of California, Los Angeles | Academic/Hospital | 1 | 1 | 1 | 2020 |
2 organizations
Page 1 / 1